Related Experiment Video
Updated: Jan 26, 2026

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors
Published on: January 1, 2017
Efficient episomal gene transfer to human hepatic cells using the pFAR4-S/MAR vector
Aristeidis Giannakopoulos1,2, Michael Quiviger3,4,5,6, Eleana Stavrou1
1Department of General Biology, Medical School, University of Patras, 26504, Rion, Patras, Greece.
This study introduces a novel non-viral gene therapy vector for liver diseases. The Scaffold/Matrix Attachment Region (S/MAR) element significantly enhances episomal gene transfer efficiency in liver cells.
Area of Science:
- Molecular Biology
- Gene Therapy
- Hepatology
Background:
- Liver-directed gene therapy holds promise for genetic and metabolic liver diseases.
- Current approaches often utilize viral vectors like AAV, which have known benefits and limitations.
- There is a need for alternative, non-viral gene transfer systems for liver applications.
Purpose of the Study:
- To develop and evaluate a novel non-viral episomal gene transfer system for liver-directed gene therapy.
- To investigate the role of the Scaffold/Matrix Attachment Region (S/MAR) element in enhancing gene transfer efficiency.
- To assess the stability and episomal nature of the gene transfer in liver cells.
Main Methods:
- Construction of pFAR4 miniplasmid vectors with and without the S/MAR element, incorporating the eGFP gene under a liver-specific promoter.
- Lipofection of Huh7 liver cells with experimental vectors.
- Evaluation of transfection efficiency and eGFP expression using fluorescent microscopy and flow cytometry.
- Assessment of stable transfection, plasmid persistence, and integration using colony expansion, FISH analysis, and plasmid rescue assays.
Main Results:
- The pFAR4 derivative vector containing the S/MAR element in an upstream configuration (pFAR4-S/MAR-IN) demonstrated significantly higher transfection efficiency and eGFP expression compared to control vectors.
- Stable transfections were achieved only with the pFAR4-S/MAR-IN vector, showing sustained GFP expression for at least 3 months.
- Analysis confirmed the presence of free, circular plasmids and no vector integration events, indicating stable episomal maintenance.
Conclusions:
- The S/MAR element significantly enhances the efficiency of episomal gene transfer using the pFAR4 miniplasmid vector.
- This S/MAR-containing miniplasmid vector is a promising tool for liver-directed gene therapy applications.
- The developed system offers a non-viral alternative for stable, episomal gene delivery to liver cells.
Related Concept Videos
Horizontal Gene Transfer
Cell Specific Gene Expression
Gene Therapy
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...

